Future-ready technologies for sensing the stemness of circulating tumor cells

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct. Target. Ther. 5(1), 28 (2020).
  MedlineGoogle Scholar
• 2. Deng Z, Wu S, Wang Y, Shi D. Circulating tumor cell isolation for cancer diagnosis and prognosis. EBioMedicine 83, 104237 (2022).
  Medline CASGoogle Scholar
• 3. Bates M, Mohamed BM, Ward MP et al. Circulating tumour cells: the good, the bad and the ugly. Biochim. Biophys. Acta Rev. Cancer 1878(2), 188863 (2023).
  Medline CASGoogle Scholar
• 4. Jiang M, Jin S, Han J et al. Detection and clinical significance of circulating tumor cells in colorectal cancer. Biomark. Res. 9(1), 85 (2021).
  MedlineGoogle Scholar
• 5. Huang Q, Wang Y, Chen X et al. Nanotechnology-based strategies for early cancer diagnosis using circulating tumor cells as a liquid biopsy. Nanotheranostics 2(1), 21–41 (2018). •• Discusses the challenges and potential applications of representative nanomaterials (e.g., magnetic nanoparticles, gold nanoparticles, silicon nanowires, nanopillars, carbon nanotubes, dendrimers, quantum dots, graphene oxide) and microfluidic chip technologies that incorporate nanoroughened surfaces.
  MedlineGoogle Scholar
• 6. Li W, Wang H, Zhao Z et al. Emerging nanotechnologies for liquid biopsy: the detection of circulating tumor cells and extracellular vesicles. Adv. Mater. 31(45), e1805344 (2019). • Summarizes recent developments in liquid biopsy nanomaterials, nanostructures, nanodevices and nanosensors with an emphasis on the identification and molecular characterization of circulating tumor cells and extracellular vesicles. Emerging microfluidic platforms for on-chip molecular analysis, detection and isolation are also provided.
  Medline CASGoogle Scholar
• 7. Sun ZF, Chang Y, Xia N. Recent development of nanomaterials-based cytosensors for the detection of circulating tumor cells. Biosensors (Basel) 11(8), 281 (2021). •• Summarizes the most recent advances in surface-enhanced Raman scattering, chemiluminescence, electrochemistry, photo electrochemistry, fluorescence, colorimetry and other optical and electrochemical analytical methods for the detection of circulating tumor cells.
  Medline CASGoogle Scholar
• 8. Mishra PK, Shandilya R. Nanophotonic biosensors as point-of-care tools for preventive health interventions. Nanomedicine (Lond.) 15(16), 1541–1544 (2020). • Deciphers the nanobiosensors as point-of-care tools for preventive health interventions for the end users that could precisely detect the molecular signatures in the human circulating bodily fluids with high reproducibility.
  CASGoogle Scholar
• 9. Habli Z, AlChamaa W, Saab R, Kadara H, Khraiche ML. Circulating tumor cell detection technologies and clinical utility: challenges and opportunities. Cancers (Basel) 12(7), 1930 (2020).
  Medline CASGoogle Scholar
• 10. Wang J, Gao Z, Dong M et al. CdSe@CdS quantum dot-sensitized Au/α-Fe₂O₃ structure for photoelectrochemical detection of circulating tumor cells. Mikrochim. Acta. 190(6), 221 (2023).
  Medline CASGoogle Scholar
• 11. Jou HJ, Chou LY, Chang WC et al. An automatic platform based on nanostructured microfluidic chip for isolating and identification of circulating tumor cells. Micromachines (Basel) 12(5), 473 (2021).
  MedlineGoogle Scholar
• 12. Yu Y, Yang Y, Wang F et al. Functional and biocompatible polymeric ionic liquid (PIL) – decorated immunomagnetic nanospheres for the efficient capture of rare number CTCs. Anal. Chim. Acta 1044, 162–173 (2018).
  Medline CASGoogle Scholar
• 13. Abate MF, Jia S, Ahmed MG et al. Visual quantitative detection of circulating tumor cells with single-cell sensitivity using a portable microfluidic device. Small 15(14), e1804890 (2019).
  MedlineGoogle Scholar
• 14. Kamińska A, Szymborski T, Witkowska E et al. Detection of circulating tumor cells using membrane-based SERS platform: a new diagnostic approach for ‘liquid biopsy’. Nanomaterials (Basel) 9(3), 366 (2019).
  Medline CASGoogle Scholar
• 15. Yang X, Mu D, Peng H et al. Research and application of artificial intelligence based on electronic health records of patients with cancer: systematic review. JMIR Med. Inform. 10(4), e33799 (2022).
  MedlineGoogle Scholar
• 16. Guo X, Lin F, Yi C et al. Deep transfer learning enables lesion tracing of circulating tumor cells. Nat. Commun. 13(1), 7687 (2022).
  Medline CASGoogle Scholar
• 17. Hashemzadeh H, Shojaeilangari S, Allahverdi A, Rothbauer M, Ertl P, Naderi-Manesh H. A combined microfluidic deep learning approach for lung cancer cell high throughput screening toward automatic cancer screening applications. Sci. Rep. 11(1), 9804 (2021).
  Medline CASGoogle Scholar
• 18. Ma J, Yang J, Jin Y et al. Artificial intelligence based on blood biomarkers including CTCs predicts outcomes in epithelial ovarian cancer: a prospective study. Onco. Targets Ther. 14, 3267–3280 (2021).
  MedlineGoogle Scholar
• 19. Ginghina O, Hudita A, Zamfir M et al. Liquid biopsy and artificial intelligence as tools to detect signatures of colorectal malignancies: a modern approach in patient's stratification. Front. Oncol. 12, 856575 (2022).
  Medline CASGoogle Scholar
• 20. Gong H, Dai Q, Peng P. Cell-membrane-anchored DNA logic-gated nanoassemblies for in situ extracellular bioimaging. ACS Appl. Mater. Interfaces 14(38), 43026–43034 (2022).
  Medline CASGoogle Scholar